Chief Med Onc @SylvesterCancer @UnivMiami Global access to cancer care & lung cancer Editor emeritus @ASCO JCO Global Oncology Chair #ATOMCoalition
Miami, FL
Joined November 2013
- Tweets60.2K
- Following40.5K
- Followers37.7K
- Likes85.3K
Pinned Tweet
My piece @WSJopinion online today
A Papal Scare and a Lesson in Early Detection wsj.com/opinion/a-papal-scar… via @WSJopinion
With the news that the Pope does not need any adjuvant treatment we hope that November’s Lung Cancer Awareness Month will help us redouble our efforts to prevent tobacco use and help smokers quit; expand access to low-dose computed tomography screening for those at risk; ensure prompt diagnosis and access to modern treatments; and recognize that lung cancer isn’t exclusively a smoker’s disease.
No one deserves lung cancer, whatever their smoking history. Patients need compassion, not judgment, and access to advances that can save their lives.
gilberto lopes retweeted
"We All Just Want To Be Loved" by Angelique Zobitz is our latest #poem, selected by October poetry curator Jessica L. Walsh.
zps.la/4BiSu9i
gilberto lopes retweeted
Kevan Shokat (@kevansf) made KRAS druggable. With daraxonrasib now in the clinic, he is “all in” on the ultimate target: p53
Shokat was named 2026 Stephenson Global Prize winner
cancerletter.com/conversatio…
gilberto lopes retweeted
Special congrats to @Piuchagarrido
ESMO Women for Oncology Award 2026 awarded at @myESMO #ESMO26
First chair of the W4O ESMO Commitee
First woman to be @_SEOM president
Very proud 🫶
#ESMOAmbassadors
Opening Ceremony at @myESMO #ESMO26 with the ESMO Award Ceremony
#NoemiReguart, chair of Nomination Committee presents all awardees
Congrats to all 👏🏻👏🏻👏🏻
#ESMOAmbassadors
gilberto lopes retweeted
Florida’s not buying the DSA message.
On @FoxNews, I explained why Florida’s experience with communist and socialist regimes shapes how many residents view the promises being made by today’s progressive candidates.
“They talk about the promise. They never talk about the cost.”
Joining @HarrisFaulkner LIVE on @FoxNews at 11 AM ET to discuss Florida’s elections, Bernie Sanders’ support for Senate candidate Angie Nixon, and concerns about socialist policies. Tune in to @FaulknerFocus!
gilberto lopes retweeted
Thanks for featuring our study @RadiologyBiz!! 🙏🫁🤍 #lcsm
@SylvesterCancer @umiamimedicine @UMiamiHealth @WeillCornell @Doc_EPMD @nmoise_md @rtamimi
radiologybusiness.com/topics…
gilberto lopes retweeted
VIKTOR is evolving! 🤖
First launched in 2025, IASLC's thoracic oncology knowledge platform now offers new capabilities with VIKTOR 2.0, including natural language searching, expanded cell line data, and AI-supported knowledge access.
Exclusive to full IASLC members. Explore now: iaslc.org/viktor
gilberto lopes retweeted
A new personalized mRNA vaccine for melanoma is being hailed by some oncologists as a breakthrough after reducing the risk of cancer recurrence and death by 42% compared with standard treatment in a late-stage clinical trial. nbcnews.com/health/cancer/pe…
gilberto lopes retweeted
Paper published in prestigious Journal of Translational Medicine...using antiaging vaccine to stop #cancer
Successful treatment of #glioma #breastcancer #lungcancer and #pancreaticcancer with #senolytic #immunotherapy by #immortabio
#longevity
link.springer.com/article/10…
gilberto lopes retweeted
“It is a great honor to announce that Dr. Chinburen Jigjidsuren, former Minister of Health of Mongolia and Member of the State Great Khural (Parliament) of Mongolia, has kindly agreed to join the International Advisory Board of my campaign for Director-General of the @WHO" - Dr. Gevorg Tamamyan (@GevTamamyan).
Dr Chinburen Jigjidsuren, MD, PhD, is a Mongolian oncologic surgeon. He served as General Director of the National Cancer Center of Mongolia from 2016 to 2019 and previously leaded its Hepatobiliary and Pancreatic Surgery Unit.
Read more on OncoDaily: oncodaily.com/positive/dr-ge…
gilberto lopes retweeted
The leaked Merck vaccine data @myESMO underscore the challenges of the orchestrated theater of Act 1, company press release -> Act 2 hold data -> Act 3 public report at major meetings. Act 2, the hold phase, builds excitement for the company & discussion but inevitably there are data shared with KOLs and other stakeholders.
$MRNA rose 276% (🔼mkt cap $40+B) on press release and fell 18% (🔽$12B) on leak.
Seems unclear how this orchestration helps patients or actual research. To the extent there is peer review, it is done by the journals and not the meeting organizers themselves.
@adamfeuerstein @matthewherper
wsj.com/health/pharma/modern…
gilberto lopes retweeted
Zócalo's no-fee #Poetry Prize contest opens on November 23. Read the prize details and check back for submission guidelines:zps.la/pp27
gilberto lopes retweeted
Some of the best collaborations start with unexpected encounters! ✨
Casual conversations, shared ideas, and new connections at #ESMO2026 that may turn into exciting collaborations. Sometimes, the most meaningful opportunities happen outside the meeting rooms! 🤝
gilberto lopes retweeted
Eye-opening discussion with #DrRobertJones: KEYNOTE-866 and CA017-078 fail to demonstrate significant perioperative IO benefit despite higher pCR rates, while TROPHY-U-01 explores dual ADC + PD-1 blockade in metastatic UC. Promising future therapy with more data needed!
#BladderCancer @myESMO @OncoAlert
gilberto lopes retweeted
Reflecting on Six Years of Leadership and Service at UICC - gilberto lopes (@GlopesMd)
oncodaily.com/voices/gilbert…
gilberto lopes retweeted
The price of @CityofMiami government just went up by $90 million.
Plus CFO Ingoglia @GovGoneWild flagged about $94M in excessive City spending and $302M at the County.
Now add $800M bond/debt they want us to vote for.
When does it stop?
NO on Referendum 1.
@MissionMiamiPC
gilberto lopes retweeted
A Great Day one of #ESMO26 in Madrid 🇪🇸
METRICS by AcuVox.io
Our sincere thanks to ESMO faculty and staff for a great day of science
🔥 25.6M potential reach
💬 1.6K posts on X
👥 518 voices from 26 countries
and we are just getting started!!
@cdanicas @hoperugo @DrChoueiri @TiansterZhang @matteolambe @NiuSanford @stolaney1 @christine_lovly @amerseburger @GlopesMd @tompowles1 @montypal @Icro_Meattini @PGrivasMDPhD @brian_rini @CathyEngMD @apolo_andrea @AndreaNecchi @DrSGraff @BenWestphalen @graokane @to_be_elizabeth @ElisaAgostinett @nataliagandur @UOzkerim @DrMirallas @DrYukselUrun @Lucarecco @mzugman @HHorinouchi @p_ciracimd @DraMartinezLago @DrVilmaPBarcia @GIMedOnc @MarioBalsaMD @scocmem @AmandaNizamMD @GaiaGriguolo @JankovicK @Dr_Oncologista @Erman_Akkus @WeOncologists @niklas_kluemper @Markuseckstein3 @stolaney1 @PTarantinoMD @VivekSubbiah @adamfeuerstein @urotoday
gilberto lopes retweeted
HERIZON-GEA-01 at #ESMO26:
Zanidatamab + chemotherapy improved PFS and OS versus trastuzumab-based therapy in 1L HER2+ advanced GEA. The triplet regimen with tislelizumab achieved a median OS of 27 months and a 3-year OS rate of 40%.
@OncoAlert #HER2Positive
gilberto lopes retweeted
🚨 The daily OncoAlert Newsletter is LIVE from Madrid 🇪🇸 #ESMO26
REGISTER for Free 👉 buff.ly/N5gYtAc
DELIVER STRAIGHT TO YOUR INBOX EVERY MORNING
Day One #ESMO26 is in:
📌 NATALEE 6-yr OS
📌 PANKU-Breast01 + Lancet pub
📌 KEYNOTE-866 & ENERGIZE, both negative in MIBC
📌 HERIZON-GEA-01 3-yr OS
For colleagues… by colleagues 🤝
Subscribe 👉 OncoAlert360.com
@cdanicas @hoperugo @DrChoueiri @TiansterZhang @matteolambe @NiuSanford @stolaney1 @christine_lovly @amerseburger @GlopesMd @tompowles1 @montypal @Icro_Meattini @PGrivasMDPhD @brian_rini @CathyEngMD @apolo_andrea @AndreaNecchi @DrSGraff @BenWestphalen @graokane @to_be_elizabeth @ElisaAgostinett @nataliagandur @UOzkerim @DrMirallas @DrYukselUrun @Lucarecco @mzugman @HHorinouchi @p_ciracimd @DraMartinezLago @DrVilmaPBarcia @GIMedOnc @MarioBalsaMD @scocmem @AmandaNizamMD @GaiaGriguolo @JankovicK @Dr_Oncologista @Erman_Akkus @WeOncologists @niklas_kluemper @Markuseckstein3